Presenter(s): Mark Duncan, MD and Caleb Banta-Green, PhD, MPH, MSW
Date: November 2020
In this presentation, Mark Duncan, MD and Caleb Banta-Green, PhD, MPH, MSW discussed the medication-first model for opioid use disorder (OUD) treatment. This model aims to address the underlying issues around why less than a quarter of people with OUD are on treatment medications. Many programs are designed to serve the clients most “motivated” to reduce/stop their illicit opioid use, but these criteria have the perverse effect of excluding large proportions of people who DO want to reduce/stop use but can’t initiate or sustain care in traditional appointment based health care settings.